Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-11 Sale |
2022-02-14 4:19 pm |
X4 Pharmaceuticals Inc | XFOR | Cadavid Diego Chief Medical Officer |
928 | $0 | $0 | 7,107 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 4:19 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,071 | $18.3 | $19,599 | 65,714 (Direct) |
View |
| 2020-06-25 Sale |
2020-06-26 4:17 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,459 | $22 | $32,098 | 79,062 (Direct) |
View |
| 2020-06-10 Sale |
2020-06-12 5:10 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
401 | $22 | $8,822 | 80,521 (Direct) |
View |
| 2020-06-04 Sale |
2020-06-08 4:17 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
677 | $20.14 | $13,632 | 95,510 (Direct) |
View |
| 2020-06-02 Sale |
2020-06-04 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
383 | $20.16 | $7,720 | 96,751 (Direct) |
View |
| 2020-05-28 Sale |
2020-06-01 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
800 | $20.01 | $16,007 | 97,379 (Direct) |
View |
| 2020-05-12 Sale |
2020-05-12 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,860 | $18 | $33,480 | 82,782 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-01 Option Award |
2022-03-01 4:08 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Cadavid Diego Chief Medical Officer |
97,000 | $0 | 104,107 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-25 4:56 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | Cadavid Diego Chief Medical Officer |
8,035 | $0 | 8,035 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-06 08:23 am |
N/A 2030-12-31 |
X4 Pharmaceuticals Inc | XFOR | Cadavid Diego Chief Medical Officer |
121,500 | $6.43 | 121,500 (Direct) |
View |
| 2020-06-25 Exercise |
2020-06-26 4:17 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,459 | $0 | 79,062 (Direct) |
View |
| 2020-06-25 Exercise |
2020-06-26 4:17 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,459 | $4.83 | 79,062 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:10 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
401 | $0 | 80,521 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:10 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
401 | $4.83 | 80,521 (Direct) |
View |
| 2020-06-04 Exercise |
2020-06-08 4:17 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
677 | $0 | 95,510 (Direct) |
View |
| 2020-06-04 Exercise |
2020-06-08 4:17 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
677 | $4.83 | 95,510 (Direct) |
View |
| 2020-06-02 Exercise |
2020-06-04 4:16 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
383 | $0 | 96,751 (Direct) |
View |
| 2020-06-02 Exercise |
2020-06-04 4:16 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
383 | $4.83 | 96,751 (Direct) |
View |
| 2020-05-28 Exercise |
2020-06-01 4:16 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
800 | $0 | 97,379 (Direct) |
View |
| 2020-05-28 Exercise |
2020-06-01 4:16 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
800 | $4.83 | 97,379 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-12 4:15 pm |
N/A 2028-07-10 |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,860 | $0 | 82,782 (Direct) |
View |
| 2020-05-12 Exercise |
2020-05-12 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Cadavid Diego SVP Clinical Development |
1,860 | $4.83 | 82,782 (Direct) |
View |